Taiwan FDA registration 8a35279391bae679185b1b514d88ece4
"Portex" arterial blood sampling group (sterilized)
TW: “波特克斯”動脈血液取樣組(滅菌)
Taiwan·Risk Class 1·SMITHS MEDICAL ASD, INC.;; Smiths Medical ASD, Inc.·Registered Oct 12, 2020 – Oct 12, 2025ExpiredRegistration details
- Analysis ID
- 8a35279391bae679185b1b514d88ece4
- Customs Code
- DHA09402201801
Company information
- Manufacturer Country
- United States
- Authorized Representative
- EVERMEDICAL COMPANY LTD.
Product details
- Intended Use
- It is limited to the first-level identification scope of the "Arterial Blood Sampling Group (D.1100)" of the Measures for the Classification and Grading of Medical Devices.
- Product Type (Level 1)
- D Anesthesiology
- Product Type (Level 2)
- D.1100 動脈血液取樣組
- Import Information
- QMS/QSD;; 輸入
Dates and status
- Registration Date
- Oct 12, 2020
- Expiry Date
- Oct 12, 2025
About this record
Access comprehensive regulatory information for "Portex" arterial blood sampling group (sterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 8a35279391bae679185b1b514d88ece4 and manufactured by SMITHS MEDICAL ASD, INC.;; Smiths Medical ASD, Inc.. The authorized representative in Taiwan is EVERMEDICAL COMPANY LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices